 |
Polatuzumab vedotin |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2016-12-12 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way, MS# 355E;South San Francisco, California, 94080 |
| |
Polatuzumab vedotin |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2016-12-12 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way, MS# 355E;South San Francisco, California, 94080 |